A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
modernize therapeutic equivalence rating determinations. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Modernizing Thera-
4
peutic Equivalence Rating Determination Act’’. 
5
SEC. 2. THERAPEUTIC EQUIVALENCE DETERMINATIONS. 
6
Section 505(j)(7)(A) of the Federal Food, Drug, and 
7
Cosmetic Act (21 U.S.C. 355(j)(7)(A)) is amended by 
8
adding at the end the following: 
9
03:08 Apr 05, 2022
H7377
2 
•HR 7377 IH
‘‘(v)(I) The Secretary shall make a determination 
1
under clause (i)(III)— 
2
‘‘(aa) with respect to an application submitted 
3
under this subsection, at the time of approval of 
4
such application or not later than 30 days after the 
5
date of such approval; or 
6
‘‘(bb) with respect to an application submitted 
7
under subsection (b)(2), at the time of approval of 
8
such application or not later than 30 days after the 
9
date of such approval, provided that the sponsor re-
10
quests such a determination in the original applica-
11
tion, in a form prescribed by the Secretary. 
12
‘‘(II) When the Secretary makes a determination 
13
under clause (i)(III), the Secretary shall, in revisions made 
14
to the list pursuant to clause (ii), include such information 
15
for such drug. 
16
‘‘(III) When the Secretary makes a determination 
17
under clause (i)(III) with respect to a drug, the Secretary 
18
shall, at the same time, make such a determination with 
19
respect to any other drug— 
20
‘‘(aa) whose application under subsection (b)(2) 
21
was approved; 
22
‘‘(bb) which references the same listed drug as 
23
the application for the first drug for which such de-
24
termination is made; and 
25
03:08 Apr 05, 2022
H7377
3 
•HR 7377 IH
‘‘(cc) for which there is a citizen petition pend-
1
ing requesting that the Secretary make a determina-
2
tion under clause (i)(III).’’. 
3
Æ 
03:08 Apr 05, 2022
H7377
